Newsfeeds - Spark Newswire

6 minute read

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology

Today, 3:14 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11)

ABSI

2 minute read

15 Stocks Moving in Tuesday’s Pre-Market Session

By Lisa Levin

Today, 3:14 AM

Gainers

CEI

2 minute read

Geron Highlights Publication Of Analyses Comparing Real World Data To IMbark Phase 2 In ‘Annals Of Hematology’

By Benzinga Newsdesk

Today, 3:14 AM

Analyses Suggest Survival Benefit Associated with Imetelstat Treatment in Comparison to Best Available Therapy Overall Survival is Primary Endpoint for Ongoing Phase 3 Clinical Trial in Refractory MF FOSTER CITY,

GERN

2 minute read

Earnings

Geron Earnings Perspective: Return On Capital Employed

By Benzinga Insights

Today, 3:14 AM

Benzinga Pro data, Geron (NASDAQ:GERN) reported Q2 sales of $107.00 thousand. Earnings fell to a loss of $28.89 million, resulting in a 1.53% decrease from last quarter.

GERN

8 minute read

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business

By Shanthi Rexaline

Today, 3:14 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16)

ABSI

1 minute read

Earnings

Recap: Geron Q2 Earnings

By Benzinga Insights

Today, 3:14 AM

Shares of Geron (NASDAQ:GERN) rose 2.5% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 50.00% over the past year to ($0.09), which missed the estimate of ($0.08).

GERN

1 minute read

Geron Q2 EPS $(0.09) Misses $(0.08) Estimate, Sales $107.00K Beat $60.00K Estimate

By Benzinga Newsdesk

Today, 3:14 AM

Geron (NASDAQ:GERN) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 50 percent decrease over losses of $(0.06) per share from the same

GERN

8 minute read

Earnings Scheduled For August 16, 2021

By Benzinga Insights

Today, 3:14 AM

Companies Reporting Before The Bell • Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second quarter. • Data Storage (NASDAQ:DTST) is expected to report earnings for its second quarter.

ACRX

4 minute read

30 Stocks Moving in Friday’s Pre-Market Session

By Lisa Levin

Today, 3:14 AM

Gainers

ABNB

1 minute read

News

Return On Capital Employed Overview: Geron

By Benzinga Insights

Today, 3:14 AM

During Q1, Geron's (NASDAQ:GERN) reported sales totaled $137.00 thousand. Despite a 22.3% in earnings, the company posted a loss of $28.45 million. Geron collected $50.00 thousand in revenue during Q4, but reported earnings showed a $23.27 million loss.

GERN